HIGHLIGHTS
- who: RUNX and colleagues from the University of Victoria, Canada have published the article: -Hemihydrate calcium sulfate/ n-hydroxyapatite combined with metformin promotes osteogenesis in vitro and, in the Journal: (JOURNAL)
- what: The authors attempted to use a drug to inhibit the weak inflammatory state caused by material implantation in animals and promote bone healing. This study prepared metformin (Met)/u03b1-CSH/nHA scaffolds by adding metformin in different concentrations to the originalu03b1 -CSH/nHA scaffolds, and the effects on osteogenic gene and protein expression were investigated. This approach provides a more efficient and less . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.